https://www.selleckchem.com/pr....oducts/tecovirimat.h
Half of the patients (74/15 at D30 and 40% (52/13 at D60 reported asthenia. Persistent symptoms at D60 were significantly associated with age 40 to 60years old, hospital admission and abnormal auscultation at symptom onset. At D30, severe COVID-19 and/or dyspnoea at symptom onset were additional factors associated with persistent symptoms. Up to 2months after symptom onset, two thirds of adults with noncritical COVID-19 had complaints, mainly anosmia/ageusia, dyspnoea or asthenia. A prolonged medical follow-up of patients with C
Like
Comment
Share
